Solution
Industries
Resources
About

Cancer Therapies: Technologies and Global Markets

Report Code: HLC027B

Publish Date: May 2008

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global cancer therapy market will increase from $40.0 billion in 2007 to an estimated $47.3 billion by the end of 2008. It should reach $110.6 billion in 2013, a compound annual growth rate (CAGR) of 18.5%.
  • Breast cancer therapy is the largest market with about $11.0 billion in sales in 2007. This is expected to increase to $12.0 billion by the end of 2008 and $26.5 billion in 2013, for a CAGR of 16.4%.
  • Target therapy dominated in 2007 with a 45% share of the total cancer therapy market. This is expected to increase to 48% by the end of 2008 and 62.5% in 2013.

INTRODUCTION

STUDY OBJECTIVES
 
BCC’s goal in conducting this study is to provide an overview of the current and potential aspects of the global market for cancer therapies. The report determines the market size, market leaders, and factors affecting the market for cancer therapies with the inclusion of the market by disease sector.
 
The overview of types of diseases and different therapies in cancer is also examined along with sale figures over the 5-year period from 2008 to 2013. Companies manufacturing/selling the drugs to treat cancer are profiled, and the factors affecting markets for these products and how those markets are likely to change are analyzed. Revenues have been broken down by the type of therapies and by different regions.
 
Our key objective is to present a comprehensive analysis of the current and future market and to analyze the future direction of cancer therapies with an emphasis on newer products.
 
REASONS FOR DOING THIS STUDY
 
Due to continuous technology advances in research and development in the field of oncology and the requirement for newer and more effective pharmaceutical drugs/therapies, companies are investing in the development of these new products to lessen the side effects and target the disease. A fundamental change in cancer therapies is underway with a shift from the use of chemotherapy drugs to targeted therapy or the use of chemotherapy drugs along with targeted therapies. Targeted therapies are being developed for targeting cancer cells more specifically. Targeted therapies are more efficacious and less toxic than chemotherapy due to their more selective nature.
 
This study looks at almost all types of therapies/products used in oncology. The study conducts the prevalence of cancer globally. The research and development of new products and major changes in market behavior justify focusing on this segment. Finally, this study discusses the usage of these drug therapies by disease sector to determine the usage in each sector.
 
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
 
The study contributes to the areas of market growth and decline in cancer therapies from the point of view of manufacturers and users. This study will be of interest largely to the pharmaceutical and biopharmaceutical industries, clinics, and hospitals. 
 
SCOPE OF THE STUDY
 
The scope of this study encompasses the markets for cancer therapies. BCC analyzes each market and its market leaders; different types of therapies; the prevalence of cancer; the regulatory environment; the different disease sectors for cancer; and market projections and market share. Technological issues include the latest trends and new developments
 
METHODOLOGY
 
Both primary and secondary sources were used for this research. A comprehensive literature search was conducted. The literature included technical newsletters and journals as well as many other sources. The data were collected through interviews and correspondence with various pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, likely unit prices, rates of consumption, and market trends.
 
INFORMATION SOURCES
 
BCC surveyed many companies to obtain data for this study. Included were manufacturers and end users of cancer drugs. We gathered the data; spoke with officials of this industry; and reviewed newsletters, company literature, product literature, a host of technical articles, journals, indexes, and abstracts.  Exhaustive investigations of databases by key terminology were done. In addition, we compiled data from current financial and trade information and government sources.
 
ABOUT THE AUTHOR
 
Shalini Shahani Dewan holds a Masters degree in Pharmaceutical Chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shahani was awarded a gold medal by the prime minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are “Reagents of Chromatography;” “Spectroscopy, an Enduring Market;” “Advanced Drug Delivery Systems;” “Orthopedic Drugs, Implants, and Devices;” “Imaging Reagents;” “Contract Manufacturing, Research and Packaging;” “The Dynamic Media, Sera, and Reagent market in Biotechnology;” “Opportunities in Chiral Technology;” “Behavioral and Emotional Disorders in Children and Adolescents;” and “Pharmaceutical Regulatory Industry”.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Cancer Therapies: Technologies and Global Markets 176Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW26Free
Chapter- 4: REGULATORY ISSUES13Free
Chapter- 5: PREVALENCE5Free
Chapter- 6: CLASSIFICATION OF CANCER THERAPIES12Free
Chapter- 7: INDUSTRY STRUCTURE 24Free
Chapter- 8: MARKET ANALYSIS35Free
Chapter- 9: NEW DEVELOPMENTS10Free
Chapter- 10: MARKET BY DISEASE TYPE18Free
Chapter- 11: PATENT ANALYSIS9Free
Chapter- 12: C. CRAMER & CO. GMBH17Free
Chapter- 13: APPENDIX2Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 86

  • Summary Table: THE GLOBAL CANCER THERAPY MARKET, THROUGH 2013
  • Table 1: CANCER DRUGS APPROVED BY THE FDA
  • Table 2: NEW DRUG APPLICATIONS (2005 TO JANUARY 2008)
  • Table 3: RECALLS (2005 TO JANUARY 2008)
  • Table 4: WORLDWIDE PREVALENCE OF CANCER, 2007
  • Table 5: WORLDWIDE PREVALENCE OF NEW CASES OF CANCER, BY REGION, 2007
  • Table 6: WORLDWIDE DEATHS DUE TO CANCER, BY REGION, 2007
  • Table 7: ESTIMATED NEW CANCER CASES IN THE U.S., 2007
  • Table 8: CANCER DEATHS IN THE U.S., 2007
  • Table 9: ESTIMATED NEW CANCER CASES IN EUROPE, 2007
  • Table 10: CANCER DEATHS IN EUROPE, 2007
Sample Report

Recent Reports

Global Pathology Services Market

Published - Aug 2026 | Publisher - BCC Publishing | Code - HLC317A

The global market for pathology services was valued at $225 billion in 2025 and, is estimated to reach $307.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.5% from 2025 through 2030.

Global Markets and Technologies for Electronic Health Records

Published - Aug 2026 | Publisher - BCC Publishing | Code - HLC205B

The global market for electronic health records is expected to grow from $36.5 billion in 2025 and is projected to reach $52.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.4% during the forecast period of 2025 to 2030.

Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare

Published - Jul 2026 | Publisher - BCC Publishing | Code - HLC208B

The global market for cognitive computing and Artificial Intelligence (AI) systems market in healthcare was valued at $11.4 billion in 2025 and, is estimated to reach $50.1 billion by 2030, at a compound annual growth rate (CAGR) of 34.4% from 2025 through 2030.

State of the Life Sciences Industry - 2026 Second Quarter Review

Published - Jul 2026 | Publisher - BCC Publishing | Code - HLC314D

Discover BCC Research’s Q2 2026 life sciences industry review, highlighting market trends, innovation, sector performance, and growth opportunities.

Cardiovascular Devices: Global Markets to 2030

Published - Jul 2026 | Publisher - BCC Publishing | Code - HLC210B

The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.

Top Trending Reports

State of the Life Sciences Industry - 2026 Second Quarter Review

Published - Jul 2026 | Publisher - BCC Publishing | Code - HLC314D

Discover BCC Research’s Q2 2026 life sciences industry review, highlighting market trends, innovation, sector performance, and growth opportunities.

Cardiovascular Devices: Global Markets to 2030

Published - Jul 2026 | Publisher - BCC Publishing | Code - HLC210B

The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.

Global Veterinary Medical Devices Market

Published - Jul 2026 | Publisher - BCC Publishing | Code - MDS113A

This report provides an in-depth analysis of the global veterinary medical devices market by device type, animal type, and region. It examines key market trends, technologies, competitive dynamics, and challenges influencing the industry. Regional analysis covers North America, Europe, Asia-Pacific, the Middle East & Africa, and South America, with a focus on major countries within these regions. The study also includes profiles of leading companies, highlighting financials, product portfolios, and recent developments, along with market forecasts through 2030.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Jun 2026 | Publisher - BCC Publishing | Code - BIO099G

The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.

Global HLA Typing for Transplant Market

Published - Jul 2026 | Publisher - BCC Publishing | Code - BIO277A

This report analyzes the global HLA typing for transplant market, covering market size, growth trends, industry dynamics, emerging technologies, and competitive developments. The market is segmented by product and service type, technology, application, end user, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study includes insights into key applications such as solid organ and hematopoietic stem cell transplants, along with profiles of leading companies and forecasts through 2030.

Published - Sep-2001| Analyst - Lynn Gray| Code - HLC027A

Report Highlights

  • The total worldwide cancer drug market approached $14.8 billion in 2000.
  • Growing at an average annual rate (AAGR) of 12.5%, this market is expected to exceed $26.7 billion in 2005.
  • Established product lines currently constitute nearly 90% of the market, but will grow at only a 6.6% AAGR through the period.
  • Innovative therapies, climbing at an AAGR of 40.2%, will reach $8.6 billion in 2005, representing 32% of the total market.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Cancer Therapies: Technologies and Global Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment